膀胱癌患者报告结局测量工具的系统评价:基于COSMIN清单
该研究采用COSMIN清单系统评价用于膀胱癌患者的患者报告结局测量工具(PROMs)的心理测量学性质。检索7个数据库(1990年1月至2017年9月),筛选4663条记录,最终纳入23项研究、共3568例患者。结果显示多数PROMs的心理测量学信息报告有限,膀胱癌指数(BCI)和FACT-VCI报告最详细,但无PROM在所有COSMIN测量属性上被评估,现有证据尚无法确定最合适的HRQL测量工具。
要点
- 膀胱癌PROMs心理测量学证据有限,BCI和FACT-VCI报告最详细。
- 无PROM被评估所有COSMIN属性,缺乏验证研究。
- 膀胱癌异质性及治疗多样性导致PROM选择困难。
核心结论
- 基于现有证据,尚无现有PROM在测量膀胱癌人群健康相关生活质量方面明显最合适。
- 原因包括膀胱癌及其治疗的异质性,以及缺乏验证研究导致无PROM被评估所有COSMIN测量属性。
研究设计与样本
- 系统评价,使用COSMIN清单评估报告PROM心理测量学性质的研究。
- 电子检索7个数据库(包括PubMed、MEDLINE和EMBASE),检索1990年1月至2017年9月发表的英文文献,PROSPERO注册号CRD42016051974。
- 两名研究者独立筛选摘要和全文,最终纳入23项研究,共3568例患者。
主要发现
- 共筛选4663条记录,纳入23项研究,报告3568例患者的结局。
- 多数PROMs报告的心理测量学性质信息有限。
- 报告膀胱癌指数(BCI)和FACT-VCI的研究提供最多细节,这些PROMs可在最多COSMIN属性上被评估。
临床怎么用
- 临床选择膀胱癌HRQL测量工具时需注意现有PROMs心理测量学证据有限。
- BCI和FACT-VCI报告信息相对较多,但尚无PROM被证明在所有COSMIN属性上均得到评估。
- 建议未来对通用、癌症通用和膀胱癌特异性PROMs进行评估,以更好理解其在膀胱癌人群中的应用。
局限性
- 仅纳入英文文献,检索截止2017年9月。
- 多数PROMs心理测量学信息报告有限,缺乏验证研究。
- 无PROM被评估所有COSMIN测量属性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patient-reported outcome measures (PROMs) are important tools used to understand patient-focused outcomes from care. Various PROMs have been developed for patients with bladder cancer (BC), although the disease's heterogeneity makes selection difficult. Accurate measurement of health-related quality of life (HRQL) can only be achieved if the PROM chosen is 'fit for purpose' (i.e. psychometrically sound). Systematic reviews of psychometric properties are useful for selecting the best PROM for a specific purpose. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) developed a checklist to improve the selection of health measurement instruments as part of a review process. Our aims were to undertake a systematic review, using the COSMIN criteria, to assess the quality of studies that report the psychometric properties of PROMs used with people with BC and determine the psychometric quality of these PROMs. An electronic search of seven databases including PubMed, MEDLINE and EMBASE (PROSPERO reference CRD42016051974) was undertaken to identify English language publications, published between January 1990 and September 2017 that evaluated psychometric properties of PROMs used in BC research. Two researchers independently screened abstracts and selected full-text papers. Studies were rated on methodological quality using the COSMIN checklist. Overall, 4663 records were screened and 23 studies, reporting outcomes in 3568 patients, were evaluated using the COSMIN checklist. Most PROMs had limited information reported about their psychometric properties. Studies reporting on the Bladder Cancer Index (BCI) and Functional Assessment of Cancer Therapy Vanderbilt Cystectomy Index (FACT-VCI) provided the most detail and these PROMs could be evaluated on the most COSMIN properties. Based on the available evidence, no existing PROM stands out as the most appropriate to measure HRQL in BC populations. This is due to two factors; (i) the heterogeneity of BC and its treatments (ii) no PROM was evaluated on all COSMIN measurement properties due to a lack of validation studies. We suggest future evaluation of generic, cancer generic and BC-specific PROMs to better understand their application with BC populations and propose strategies to help clinicians and researchers.
引用
- Mason SJ, Catto JWF, Downing A, et al. Evaluating patient-reported outcome measures (PROMs) for bladder cancer: a systematic review using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist. BJU Int. 2018. PMID: 29726085. doi:10.1111/bju.14368
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。